Latest filings (excl ownership)
8-K
Other Events
3 Mar 25
8-K
Entry into a Material Definitive Agreement
30 Dec 24
8-K
Regulation FD Disclosure
10 Dec 24
8-K
Departure of Directors or Certain Officers
14 Nov 24
10-Q
2024 Q3
Quarterly report
7 Nov 24
8-K
Chimerix Reports Third Quarter 2024 Financial Results and Provides Operational Update
7 Nov 24
S-8
Registration of securities for employees
13 Aug 24
10-Q
2024 Q2
Quarterly report
13 Aug 24
8-K
Chimerix Reports Second Quarter 2024 Financial Results and Provides Operational Update
13 Aug 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
3 Jul 24
8-K
Submission of Matters to a Vote of Security Holders
21 Jun 24
EFFECT
Notice of effectiveness
6 May 24
10-Q
2024 Q1
Quarterly report
1 May 24
8-K
Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update
1 May 24
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
8-K
Chimerix Appoints Marc D. Kozin to Board of Directors
21 Mar 24
S-3
Shelf registration
29 Feb 24
10-K
2023 FY
Annual report
29 Feb 24
8-K
Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
29 Feb 24
8-K
Chimerix Appoints Lisa Decker to Board of Directors
29 Dec 23
8-K
Departure of Directors or Certain Officers
4 Dec 23
8-K
Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer
16 Nov 23
10-Q
2023 Q3
Quarterly report
2 Nov 23
8-K
Chimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update
2 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
8-K
Chimerix Reports Second Quarter 2023 Financial Results and Provides Operational Update
3 Aug 23
8-K
Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer
27 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
12 Jun 23
10-Q
2023 Q1
Quarterly report
4 May 23
8-K
Chimerix Reports First Quarter 2023 Financial Results and Provides Operational Update
4 May 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
8-K
Regulation FD Disclosure
10 Mar 23
S-8
Registration of securities for employees
2 Mar 23
10-K
2022 FY
Annual report
2 Mar 23
8-K
Chimerix Reports Fourth Quarter and Year End 2022 Financial Results and Provides Operational Update
2 Mar 23
8-K
Regulation FD Disclosure
12 Jan 23
8-K
Chimerix Announces Successful Launch of ONC201 Phase 3 ACTION Study at Society for Neuro-Oncology Conference and Provides Operational Update
9 Dec 22
10-Q
2022 Q3
Quarterly report
3 Nov 22
Latest ownership filings
4
Allen S. Melemed
14 Feb 25
4
Michael T. Andriole
14 Feb 25
4
Michael Albert Alrutz
14 Feb 25
4
David Jakeman
14 Feb 25
4
Michelle LaSpaluto
14 Feb 25
144
Notice of proposed sale of securities
13 Feb 25
144
Notice of proposed sale of securities
13 Feb 25
144
Notice of proposed sale of securities
13 Feb 25
144
Notice of proposed sale of securities
13 Feb 25
144
Notice of proposed sale of securities
13 Feb 25
4
David Jakeman
31 Jan 25
4
Michelle LaSpaluto
31 Jan 25
4
Michael T. Andriole
31 Jan 25
144
Notice of proposed sale of securities
30 Jan 25
144
Notice of proposed sale of securities
30 Jan 25
144
Notice of proposed sale of securities
30 Jan 25
4
Michelle LaSpaluto
10 Jan 25
4
Allen S. Melemed
10 Jan 25
4
David Jakeman
10 Jan 25
4
Thomas J Riga
10 Jan 25
4
Michael Albert Alrutz
10 Jan 25
4
Michael T. Andriole
10 Jan 25
4
FRED A MIDDLETON
30 Oct 24
144
Notice of proposed sale of securities
9 Aug 24
4
Michael T. Andriole
9 Aug 24
4
Victoria Vakiener
21 Jun 24
4
Pratik S Multani
21 Jun 24
4
FRED A MIDDLETON
21 Jun 24
4
Robert J. Meyer
21 Jun 24
4
MARC D KOZIN
21 Jun 24
4
Lisa Lynn Decker
21 Jun 24
4
MARTHA J DEMSKI
21 Jun 24
4
Michael A. Sherman
21 Jun 24
4
MARC D KOZIN
21 Mar 24
3
MARC D KOZIN
21 Mar 24
4
Michael T. Andriole
16 Feb 24
4
Michelle LaSpaluto
16 Feb 24
4
David Jakeman
16 Feb 24
SC 13G/A
RA CAPITAL MANAGEMENT, L.P.
14 Feb 24
144
Notice of proposed sale of securities
14 Feb 24